All Articles

Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer

Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness

Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformation

The genetic architecture of bone metastases: unveiling the role of epigenetic and genetic modifications in drug resistance

Mechanisms of resistance to NAMPT inhibitors in cancer

Circular RNAs modulate cancer drug resistance: advances and challenges

Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML

Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis

Research advances in natural sesquiterpene lactones: overcoming cancer drug resistance through modulation of key signaling pathways

Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer types

The epigenetic mechanisms involved in the treatment resistance of glioblastoma

Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing

Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches

Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance

Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers

Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression